Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Consumables • Instruments • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Hospitals and clinics • Clinical diagnostic laboratories • Home care settings PART 10: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • POC blood glucose monitoring devices market in Americas • POC blood glucose monitoring devices market in EMEA • POC blood glucose monitoring devices market in APAC • Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Paradigm shift towards non-invasive products • Increase in online product sales • Product bundling PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive landscape PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • ARKRAY • Ascensia Diabetes Care • Danaher • F. Hoffmann-La Roche • Johnson & Johnson • Other prominent vendors • List of abbreviations List of Exhibits Exhibit 01: Parent market Exhibit 02: Global IVD market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global – Year over year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Global POC blood glucose monitoring devices by Product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Consumables – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Product 1 – Year over year growth 2018-2022 (%) Exhibit 22: Product 2 – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Product 2 – Year over year growth 2018-2022 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Global POC blood glucose monitoring devices market by end-user – Market share 2027 (%) Exhibit 27: Global POC blood glucose monitoring devices – Market share by geography 2017-2022 (%) Exhibit 28: Regional comparison Exhibit 29: POC blood glucose monitoring devices market in the Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 30: POC blood glucose monitoring devices market in the Americas – Year over year growth 2018-2022 (%) Exhibit 31: Top 3 countries in Americas Exhibit 32: POC blood glucose monitoring devices market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 33: POC blood glucose monitoring devices market in EMEA – Year over year growth 2018-2022 (%) Exhibit 34: Top 3 countries in EMEA Exhibit 35: POC blood glucose monitoring devices market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 36: POC blood glucose monitoring devices market in APAC – Year over year growth 2018-2022 (%) Exhibit 37: Top 3 countries in APAC Exhibit 38: Global POC blood glucose monitoring devices market opportunity Exhibit 39: Various programs to reduce cost burden for diabetics Exhibit 40: Vendor landscape Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Landscape disruption Exhibit 44: Competitive structure analysis of global POC blood glucose monitoring devices market 2016 Exhibit 45: Vendors covered Exhibit 46: Vendors covered Exhibit 47: Vendor classification Exhibit 48: Vendor classification Exhibit 49: Market positioning of vendors Exhibit 50: Market positioning of vendors Exhibit 51: Abbott overview Exhibit 52: Abbott – Business segments Exhibit 53: Abbott – Organizational developments Exhibit 54: Abbott – Geographic focus Exhibit 55: Abbott– Segment focus Exhibit 56: Abbott – Key offerings Exhibit 57: Abbott – Key customers Exhibit 58: ARKRAY overview Exhibit 59: ARKRAY – Business segments Exhibit 60: ARKRAY – Organizational developments Exhibit 61: ARKRAY– Geographic focus Exhibit 62: ARKRAY– Segment focus Exhibit 63: ARKRAY – Key offerings Exhibit 64: ARKRAY– Key customers Exhibit 65: Ascensia Diabetes Care overview Exhibit 66: Ascensia Diabetes Care– Business segments Exhibit 67: Ascensia Diabetes Care – Organizational developments Exhibit 68: Ascensia Diabetes Care – Geographic focus Exhibit 69: Ascensia Diabetes Care – Segment focus Exhibit 70: Ascensia Diabetes Care – Key offerings Exhibit 71: Ascensia Diabetes Care – Key customers Exhibit 72: Danaher overview Exhibit 73: Danaher – Business segments Exhibit 74: Danaher – Organizational developments Exhibit 75: Danaher – Geographic focus Exhibit 76: Danaher – Segment focus Exhibit 77: Danaher– Key offerings Exhibit 78: Danaher– Key customers Exhibit 79: F. Hoffmann-La Roche overview Exhibit 80: F. Hoffmann-La Roche – Business segments Exhibit 81: F. Hoffmann-La Roche– Organizational developments Exhibit 82: F. Hoffmann-La Roche – Geographic focus Exhibit 83: F. Hoffmann-La Roche – Segment focus Exhibit 84: F. Hoffmann-La Roche – Key offerings Exhibit 85: F. Hoffmann-La Roche – Key customers Exhibit 86: Vendor overview Exhibit 87: Vendor 1 – Business segments Exhibit 88: Vendor 1 – Organizational developments Exhibit 89: Vendor 1 – Geographic focus Exhibit 90: Vendor 1 – Segment focus Exhibit 91: Vendor 1 – Key offerings Exhibit 92: Vendor 1 – Key customers

Abbott, ARKRAY, Ascensia Diabetes Care, Danaher, F. Hoffmann -La Roche, and Johnson & Johnson